BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, Ezaki T. Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg. 2011;201:186-191. [PMID: 20832047 DOI: 10.1016/j.amjsurg.2010.01.030] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu FG, Vashist YK, Izbicki JR, Bogoevski D. Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment. Surgery 2016;159:1548-56. [DOI: 10.1016/j.surg.2016.01.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
2 Lin JX, Tang YH, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang CM, Li P, Zheng CH, Xie JW. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients. World J Gastroenterol 2019; 25(41): 6258-6272 [PMID: 31749596 DOI: 10.3748/wjg.v25.i41.6258] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Mikkelsen S, Køhler M, Østergaard T, Rasmussen HH. Different GLIM criteria combinations change prevalence of malnutrition in patients with intestinal insufficiency or intestinal failure. Clin Nutr ESPEN 2021;44:449-57. [PMID: 34330504 DOI: 10.1016/j.clnesp.2021.04.012] [Reference Citation Analysis]
4 Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol 2016;51:153-61. [PMID: 26187429 DOI: 10.1007/s00535-015-1103-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
5 Yamauchi Y, Safi S, Muley T, Warth A, Herth FJF, Dienemann H, Hoffmann H, Eichhorn ME. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients. Lung Cancer 2017;114:62-7. [PMID: 29173768 DOI: 10.1016/j.lungcan.2017.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang P, Xi M, Li QQ, He LR, Liu SL, Zhao L, Shen JX, Liu MZ. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer 2014;5:689-95. [PMID: 25258650 DOI: 10.7150/jca.9569] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
7 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients. World J Surg. 2018;42:1819-1825. [PMID: 29270656 DOI: 10.1007/s00268-017-4400-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
8 Díaz Del Arco C, Estrada Muñoz L, Ortega Medina L, Chávez Á, Ruiz Adelantado I, García Gómez de Las Heras S, Fernández Aceñero MJ. Update, validation and comparison of three different clinicopathological scores for patients with resected gastric cancer: A western experience. Ann Diagn Pathol 2020;49:151635. [PMID: 32980616 DOI: 10.1016/j.anndiagpath.2020.151635] [Reference Citation Analysis]
9 Shimoda Y, Fujikawa H, Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Katsumata K, Tsuchida A, Ogata T, Oshima T. Preoperative Utility of the Glasgow Prognostic Score on Outcomes of Patients with Locally Advanced Gastric Cancer. J Gastrointest Cancer 2021. [PMID: 33460001 DOI: 10.1007/s12029-021-00584-3] [Reference Citation Analysis]
10 Kubota T, Hiki N, Nunobe S, Kumagai K, Aikou S, Watanabe R, Sano T, Yamaguchi T. Significance of the Inflammation-Based Glasgow Prognostic Score for Short- and Long-Term Outcomes After Curative Resection of Gastric Cancer. J Gastrointest Surg 2012;16:2037-44. [DOI: 10.1007/s11605-012-2036-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
11 Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20(16): 4586-4596 [PMID: 24782611 DOI: 10.3748/wjg.v20.i16.4586] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
12 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
13 Wen J, Bedford M, Begum R, Mitchell H, Hodson J, Whiting J, Griffiths E. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma. J Surg Oncol. 2018;117:1697-1707. [PMID: 29761518 DOI: 10.1002/jso.25057] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
14 Asakawa A, Ishibashi H, Matsuyama Y, Fujiwara T, Kobayashi M, Okubo K. Preoperative nutritional status is associated with the prognosis for lung cancer. Asian Cardiovasc Thorac Ann 2021;:2184923211014002. [PMID: 33957785 DOI: 10.1177/02184923211014002] [Reference Citation Analysis]
15 Liu DQ, Li FF, Jia WH. Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy. Chin J Cancer 2016;35:11. [PMID: 26754834 DOI: 10.1186/s40880-015-0062-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Roxburgh CS, Wallace AM, Guthrie GK, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis. 2010;12:987-994. [PMID: 25216413 DOI: 10.9738/intsurg-d-13-00118.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
17 Kato A, Tsuji T, Sakao Y, Ohashi N, Yasuda H, Fujimoto T, Takita T, Furuhashi M, Kumagai H. A comparison of systemic inflammation-based prognostic scores in patients on regular hemodialysis. Nephron Extra 2013;3:91-100. [PMID: 24403910 DOI: 10.1159/000355148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
18 McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534-540. [PMID: 22995477 DOI: 10.1016/j.ctrv.2012.08.003] [Cited by in Crossref: 633] [Cited by in F6Publishing: 635] [Article Influence: 63.3] [Reference Citation Analysis]
19 Roncolato FT, Berton-rigaud D, O'connell R, Lanceley A, Sehouli J, Buizen L, Okamoto A, Aotani E, Lorusso D, Donnellan P, Oza A, Avall-lundqvist E, Berek J, Hilpert F, Ledermann JA, Kaminsky MC, Stockler MR, King MT, Friedlander M. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS). Gynecologic Oncology 2018;148:36-41. [DOI: 10.1016/j.ygyno.2017.10.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
20 Dias Rodrigues V, Barroso de Pinho N, Abdelhay E, Viola JP, Correia MI, Brum Martucci R. Nutrition and Immune-Modulatory Intervention in Surgical Patients With Gastric Cancer. Nutr Clin Pract. 2017;32:122-129. [PMID: 27329862 DOI: 10.1177/0884533616653807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
21 Imaoka H, Mizuno N, Hara K, Hijioka S, Tajika M, Tanaka T, Ishihara M, Yogi T, Tsutsumi H, Fujiyoshi T, Sato T, Shimizu Y, Niwa Y, Yamao K. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study. Pancreas 2016;45:211-7. [PMID: 26495775 DOI: 10.1097/MPA.0000000000000446] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
22 Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Am J Surg. 2012;204:294-299. [PMID: 22444831 DOI: 10.1016/j.amjsurg.2011.10.015] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
23 Hacker UT, Hasenclever D, Baber R, Linder N, Busse H, Obermannova R, Zdrazilova-Dubska L, Valik D, Lordick F. Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial. Ann Oncol 2022:S0923-7534(22)00670-6. [PMID: 35395383 DOI: 10.1016/j.annonc.2022.03.274] [Reference Citation Analysis]
24 Freitas C, Jacob M, Tavares N, Cruz-Martins N, Souto-Moura C, Araújo D, Novais-Bastos H, Santos V, Fernandes G, Magalhães A, Hespanhol V, Queiroga H. Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents. Anticancer Drugs 2021;32:567-74. [PMID: 33661189 DOI: 10.1097/CAD.0000000000001060] [Reference Citation Analysis]
25 Arulananda S, Segelov E. Sarcopenia and cancer-related inflammation measurements in advanced gastric and junctional cancers – Ready for prime time? Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.04.008] [Reference Citation Analysis]
26 Dolan RD, McMillan DC. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score. Crit Rev Oncol Hematol 2020;150:102962. [PMID: 32344318 DOI: 10.1016/j.critrevonc.2020.102962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
27 Fletcher J, Woodham D, Dera M, Cooper SC. Home parenteral nutrition in patients receiving palliative care: a curriculum-based review. Frontline Gastroenterol 2019;10:421-6. [PMID: 31656569 DOI: 10.1136/flgastro-2018-101113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Abe T, Tashiro H, Hattori M, Kuroda S, Tahara H, Ohira M, Kobayashi T, Ide K, Ishiyama K, Ohdan H. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res 2016;46:622-33. [PMID: 26407064 DOI: 10.1111/hepr.12597] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
29 Feng JF, Huang Y, Chen QX. The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl Oncol 2014;7:632-7. [PMID: 25389458 DOI: 10.1016/j.tranon.2014.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
30 Hanai N, Sawabe M, Kimura T, Suzuki H, Ozawa T, Hirakawa H, Fukuda Y, Hasegawa Y. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer. Oncotarget 2018;9:37008-16. [PMID: 30651931 DOI: 10.18632/oncotarget.26438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Tokuyama N, Takegawa N, Nishikawa M, Sakai A, Mimura T, Kushida S, Tsumura H, Yamamoto Y, Miki I, Tsuda M. Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer. PLoS One 2021;16:e0247645. [PMID: 33635904 DOI: 10.1371/journal.pone.0247645] [Reference Citation Analysis]
32 Kawashima M, Murakawa T, Shinozaki T, Ichinose J, Hino H, Konoeda C, Tsuchiya T, Murayama T, Nagayama K, Nitadori J, Anraku M, Nakajima J. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery. Interact Cardiovasc Thorac Surg 2015;21:637-43. [PMID: 26269495 DOI: 10.1093/icvts/ivv223] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
33 Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One 2015;10:e0143080. [PMID: 26717416 DOI: 10.1371/journal.pone.0143080] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 16.1] [Reference Citation Analysis]
34 Kato T, Ono H, Fujii M, Akahoshi K, Ogura T, Ogawa K, Ban D, Kudo A, Tanaka S, Tanabe M. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PLoS One 2021;16:e0252917. [PMID: 34111175 DOI: 10.1371/journal.pone.0252917] [Reference Citation Analysis]
35 Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, Toyokawa A. Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers? Gastroenterology Res 2017;10:359-65. [PMID: 29317944 DOI: 10.14740/gr943w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kaneko G, Shirotake S, Nishimoto K, Miyazaki Y, Ito K, Ito Y, Hagiwara M, Kanao K, Nakagawa K, Momma T, Asano T, Tanaka N, Mizuno R, Oya M, Oyama M. Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy. Jpn J Clin Oncol 2019;49:780-5. [PMID: 31063191 DOI: 10.1093/jjco/hyz067] [Reference Citation Analysis]
37 Kimura J, Kunisaki C, Makino H, Oshima T, Ota M, Oba M, Takagawa R, Kosaka T, Ono HA, Akiyama H, Endo I. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer. Dis Esophagus 2016;29:1071-80. [PMID: 26471766 DOI: 10.1111/dote.12420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
38 Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kondo T, Kitagawa Y. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg 2018;267:527-31. [PMID: 27984214 DOI: 10.1097/SLA.0000000000002115] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
39 Wang Y, Li P, Li J, Lai Y, Zhou K, Wang X, Che G. The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis. Cancer Manag Res 2019;11:8181-90. [PMID: 31564977 DOI: 10.2147/CMAR.S203425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Liu J, Geng Q, Chen S, Liu X, Kong P, Zhou Z, Zhan Y, Xu D. Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy. Oncotarget 2016;7:37556-65. [PMID: 27121054 DOI: 10.18632/oncotarget.8788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
41 Matsuda S, Takeuchi H, Kawakubo H, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Kitagawa Y. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol 2015;22:302-10. [PMID: 24952029 DOI: 10.1245/s10434-014-3857-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
42 Han G, Shi J, Mi L, Li N, Shi H, Li C, Shan B, Yin F. Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer. Future Oncol 2019;15:1617-27. [PMID: 31038363 DOI: 10.2217/fon-2018-0439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
43 Zhang CX, Wang SY, Chen SQ, Yang SL, Wan L, Xiong B. Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis. Onco Targets Ther 2016;9:3883-91. [PMID: 27390529 DOI: 10.2147/OTT.S103996] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
44 Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, Sano T, Yamaguchi T. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275-279. [PMID: 22713657 DOI: 10.1038/bjc.2012.262] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
45 Hasegawa H, Fujitani K, Nakazuru S, Hirao M, Mita E, Tsujinaka T. Optimal indications for second-line chemotherapy in advanced gastric cancer. Anticancer Drugs. 2012;23:465-470. [PMID: 22227714 DOI: 10.1097/cad.0b013e3283504442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
46 Pan M, Zhao Y, He J, Wu H, Pan Y, Yu Q, Zhou S. Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer. J Cancer 2021;12:2395-402. [PMID: 33758615 DOI: 10.7150/jca.52215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Chen Z, Nonaka H, Onishi H, Nakatani E, Sato Y, Funayama S, Watanabe H, Komiyama T, Kuriyama K, Marino K, Aoki S, Araya M, Tominaga L, Saito R, Maehata Y, Oguri M, Saito M. Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study. J Radiat Res 2021;62:457-64. [PMID: 33866376 DOI: 10.1093/jrr/rrab021] [Reference Citation Analysis]
48 Fletcher J, Woodham D, Dera M, Cooper SC. Home parenteral nutrition during palliative care: little benefit. BMJ Support Palliat Care. [DOI: 10.1136/bmjspcare-2018-001736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Hirashima K, Watanabe M, Shigaki H, Imamura Y, Ida S, Iwatsuki M, Ishimoto T, Iwagami S, Baba Y, Baba H. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49:1040-1046. [PMID: 23821018 DOI: 10.1007/s00535-013-0855-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
50 Nakayama Y, Gotohda N, Shibasaki H, Nomura S, Kinoshita T, Hayashi R. Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer. Surg Today. 2014;44:2146-2152. [PMID: 24831660 DOI: 10.1007/s00595-014-0917-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
51 Nakamura M, Iwahashi M, Nakamori M, Ojima T, Katsuda M, Iida T, Hayata K, Kato T, Yamaue H. New prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today 2014;44:875-83. [PMID: 23784105 DOI: 10.1007/s00595-013-0628-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
52 Hsueh SW, Liu KH, Hung CY, Kuo YC, Tsai CY, Hsu JT, Hung YS, Tsang NM, Chou WC. Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer. J Clin Med 2019;8:E1448. [PMID: 31547247 DOI: 10.3390/jcm8091448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
53 Lu S, Yan M, Li C, Yan C, Zhu Z, Lu W. Machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy. Chin J Cancer Res 2019;31:797-805. [PMID: 31814683 DOI: 10.21147/j.issn.1000-9604.2019.05.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kraft J, van Timmeren JE, Frei S, Mayinger M, Borsky K, Kirchner C, Stark LS, Tanadini-Lang S, Wolpert F, Weller M, Woodruff HC, Guckenberger M, Andratschke N. Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective. Radiother Oncol 2022:S0167-8140(22)00230-4. [PMID: 35489445 DOI: 10.1016/j.radonc.2022.04.024] [Reference Citation Analysis]
55 Chen XD, Mao CC, Wu RS, Zhang WT, Lin J, Sun XW, Chi CH, Lou N, Wang PF, Shen X, Zhu GB, Shen SR. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer. PLoS One 2017;12:e0175074. [PMID: 28384215 DOI: 10.1371/journal.pone.0175074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
56 Takeuchi M, Kawakubo H, Mayanagi S, Suzuki Y, Okabayashi K, Yamashita T, Kamiya S, Irino T, Fukuda K, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y. Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer. Gastric Cancer 2019;22:624-31. [PMID: 30478691 DOI: 10.1007/s10120-018-0896-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]